News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kolltan Pharmaceuticals Inc. Appoints Carolyn F. Sidor, M.D., as Chief Medical Officer


9/9/2013 7:03:15 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced the appointment of Carolyn F. Sidor, M.D., as Senior Vice President and Chief Medical Officer. Dr. Sidor will report to Dr. Jerry McMahon, Kolltan’s President and Chief Executive Officer. In addition, Kolltan announced today the appointments of Paul Medeiros to the Company’s Board of Directors and Roy Herbst, M.D., Ph.D., and Thomas Mehrling, M.D., Ph.D., to the Company’s Scientific Advisory Board.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES